SCHEMBL21667264

SCHEMBL21667264

CC(C)n1c(=O)cc(NCc2c(F)cccc2F)[nH]c1=O

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.51
▸ CYP2B6 P20813 1/20 0.51
▸ PGR P06401 7/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ MAPT P10636 1/20 0.38
▸ TP53 P04637 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ POLB P06746 2/20 0.35
▸ HTT P42858 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21667337 0.86 CYP3A4 (0.53) CYP3A4CYP2B6PGRKDM4EMAPT
SCHEMBL21667176 0.82 CYP3A4 (0.49) CYP3A4CYP2B6PGRKDM4EMAPT
SCHEMBL21667332 0.81 CYP3A4 (0.49) CYP3A4CYP2B6PGRMAPTTP53
SCHEMBL20716038 0.80 CYP3A4 (0.61) CYP3A4CYP2B6KDM4EMAPTTP53
SCHEMBL21667339 0.80 CYP3A4 (0.46) CYP3A4CYP2B6PGRTP53SMN1; SMN2
SCHEMBL24469691 0.79 EED (0.46) —
SCHEMBL21667306 0.79 CYP3A4 (0.50) CYP3A4CYP2B6PGRMAPTTP53
SCHEMBL21667347 0.79 CYP3A4 (0.50) CYP3A4CYP2B6TP53SMN1; SMN2MEN1
SCHEMBL16321847 0.78 CYP3A4 (0.66) CYP3A4CYP2B6PGRSMN1; SMN2ALDH1A1
SCHEMBL16321851 0.78 CYP3A4 (0.66) CYP3A4CYP2B6PGRSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3702352-A1 PYRIMIDINEDIONE COMPOUND AGAINST CARDIAC CONDITIONS Myokardia, Inc. (US) 2020-09-02 — — EP disclosed
EP-3010910-B1 PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS MYOKARDIA INC (US) 2020-02-05 — — EP disclosed
Send feedback